Authors
Loading...
Pilot study finds a cost-effective qPCR assay detects SMN1 gene deletion in newborns, highlighting its potential for presymptomatic SMA screening.
Coliban et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: